Onderzoeker
Gilbert Verbeken
- Trefwoorden:Geneeskunde
- Disciplines:Humane wetenschappen en de kunsten, Ingenieurswetenschappen en technologie, Natuurwetenschappen
Affiliaties
- Snijdende Klinische wetenschappen (Departement)
Lid
Vanaf1 jan 2014 → 30 sep 2015 - Huid Immunologie & Immuun Tolerantie Onderzoeksgroep (Onderzoeksgroep)
Lid
Vanaf1 okt 2006 → 30 sep 2015 - Specialiteiten (KNO, Dermatologie, Oftalmologie, Psychiatrie) (Departement)
Lid
Vanaf1 jul 2006 → 31 dec 2013
Publicaties
1 - 10 van 14
- Stability of bacteriophages in burn wound care products(2017)
Auteurs: Maia Merabishvili, Riet Monserez, Jonas van Belleghem, Thomas Rose, Serge Jennes, Daniel De Vos, Gilbert Verbeken, Mario Vaneechoutte, Jean-Paul Pirnay
Pagina's: e0182121 - Access to bacteriophage therapy(2016)
Auteurs: Gilbert Verbeken, Isabelle Huys, Daniel De Vos, Arlette De Coninck, Diane Roseeuw, E. Kets, Alain Vanderkelen, Jean Pierre Draye, Thomas Rose, S. Jennes, et al.
- Quality and safety requirements for sustainable phage therapy products(2015)
Auteurs: Jean-Paul Pirnay, Bob G Blasdel, Laurent Bretaudeau, Angus Buckling, Nina Chanishvili, Jason R Clark, Sofia Corte-Real, Laurent Debarbieux, Alain Dublanchet, Daniel De Vos, et al.
Pagina's: 2173-2179 - Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium.(2015)
Auteurs: Jean-Paul Pirnay, E. Baudoux, Olivier Cornu, Alain Delforge, Christian Delloye, Johan Guns, Ernst Heinen, Etienne Van den Abbeel, Alain Vanderkelen, Caroline Van Geyt, et al.
Pagina's: 557-562 - Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium(2015)
Auteurs: Jean-Paul Pirnay, Etienne Baudoux, Olivier Cornu, Alain Delforge, Christian Delloye, Johan Guns, Ernst Heinen, Etienne Van Den Abbeel, Alain Vanderkelen, Caroline Van Geyt, et al.
Pagina's: 557-562 - Cleanrooms and tissue banking how happy I could be with either GMP or GTP?(2013)
Auteurs: J. Klykens, Jean-Paul Pirnay, O. Giet, E. Baudoux, R. Jashari, Alain Vanderkelen, Nadine Ectors, Gilbert Verbeken, Univ Hosp, Uz Gasthuisberg, et al.
Pagina's: 571-578 - Paving a regulatory pathway for phage therapy - Europe should muster the resources to financially, technically and legally support the introduction of phage therapy(2013)
Auteurs: Jean-Paul Pirnay, Lavigne Rob, S. Jennes, D. De Vos, Minne Casteels, Gilbert Verbeken
Pagina's: 951-954 - Key issues in phage therapy: a report of a dedicated workshop at the viruses of microbes II meeting(2013)
Auteurs: M Van Eeckhoutte, Gilbert Verbeken, Laurent Debarbieux
Pagina's: 806-810 - Stability of Staphylococcus aureus Phage ISP after Freeze-Drying (Lyophilization)(2013)
Auteurs: Maia Meribishvili, C. Vervaet, Jean-Paul Pirnay, D. Devos, Gilbert Verbeken, Jan Mast, Nino Chanisvili, Mario Vaneeckoutte
- Biosimilars and market access: a question of comparability and costs?(2012)
Auteurs: S. Simoens, Gilbert Verbeken, Katholieke Univ Leuven, Fac Pharmaceut Sci, Res Ctr Pharmaceut Care, [No Value] Pharmacoecon
Pagina's: 227-231